Tomasz Adamusiak is a clinician and Director of Medical Informatics at Pfizer. He leads the medical informatics team in the Digital Medicine & Translational Imaging (DM&TI) group in the Early Clinical Development (ECD) division and is responsible for the clinical data strategy, as well as overseeing clinical data management, ensuring compliance with CDISC, 21 CFR Part 11, ICH/GCP guidelines, and clinical trial methodology across all phases and therapeutic areas. His team works closely with technical and clinical experts, as well as with the data science teams. Dr Adamusiak provides clinical support to study teams in consenting, study eligibility evaluation, monitoring, protocol, and data reviews.
The mission of the Digital Medicine group and the Pfizer Innovation Research (PfIRe) Lab is to solve key business problems using dynamical measures and advanced-STEM platforms. The goal is to utilize digital remote monitoring of patients' symptoms to develop and validate novel clinical endpoints for disease diagnosis and health state assessment.
Before Pfizer, Tomasz led the development of Big Data and Knowledge Graph solutions for life sciences and financial markets at Thomson Reuters. He served in leadership and advisory roles in the American Medical Informatics Association, the SNOMED International, and the Epic Research Data Network. He published several highly-cited research papers in peer-reviewed journals and is a frequent speaker at life sciences conferences.
By three methods we may learn wisdom: first, by reflection, which is noblest; second, by imitation, which is easiest; and third by experience, which is the bitterest.